Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Randomized Study to Evaluate the Effect of Early Treatment of Anemia With Epoetin Alfa on Hemoglobin, the Incidence of Blood Transfusions and Quality of Life in Patients Receiving Platinum-containing Chemotherapy

NCT00283465 is registered in ClinicalTrials.gov with Janssen-Cilag B.V. as lead sponsor.

NCT NCT00283465
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00283465 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Randomized Study to Evaluate the Effect of Early Treatment of Anemia With Epoetin Alfa on Hemoglobin, the Incidence of Blood Transfusions and Quality of Life in Patients Receiving Platinum-containing Chemotherapy
Lead sponsor
Janssen-Cilag B.V.
Phase
Phase 4
Overall status
Completed
Start date
November 30, 1999
Completion date
April 30, 2004
Enrollment
316 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, neoplasm